3LW0 | pdb_00003lw0

IGF-1RK in complex with ligand MSC1609119A-1


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.79 Å
  • R-Value Free: 
    0.185 (Depositor), 0.195 (DCC) 
  • R-Value Work: 
    0.157 (Depositor), 0.169 (DCC) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 3LW0

Ligand Structure Quality Assessment 


This is version 1.3 of the entry. See complete history

Literature

Allosteric IGF-1R Inhibitors.

Heinrich, T.Gradler, U.Bottcher, H.Blaukat, A.Shutes, A.

(2010) ACS Med Chem Lett 1: 199-203

  • DOI: https://doi.org/10.1021/ml100044h
  • Primary Citation Related Structures: 
    3LW0

  • PubMed Abstract: 

    Targeting allosteric protein sites is a promising approach to interfere selectively with cellular signaling cascades. We have discovered a novel class of allosteric insulin-like growth factor-I receptor (IGF-1R) inhibitors. 3-Cyano-1H-indole-7-carboxylic acid {1-[4-(5-cyano-1H-indol-3-yl)butyl]piperidin-4-yl}amide (10) was found with nanomolar biochemical, micromolar, cellular IGF-1R activity and no relevant interference with cellular insulin receptor signaling up to 30 μM. The allosteric binding site was characterized by X-ray crystallographic studies, and the structural information was used to explain the unique mode of action of this new class of inhibitors.


  • Organizational Affiliation
    • Merck Serono, Frankfurter Strasse 250, 64293 Darmstadt, Germany.

Macromolecule Content 

  • Total Structure Weight: 142.33 kDa 
  • Atom Count: 10,929 
  • Modeled Residue Count: 1,168 
  • Deposited Residue Count: 1,216 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Insulin-like growth factor 1 receptor
A, B, C, D
304Homo sapiensMutation(s): 2 
Gene Names: IGF1R
EC: 2.7.10.1
UniProt & NIH Common Fund Data Resources
Find proteins for P08069 (Homo sapiens)
Explore P08069 
Go to UniProtKB:  P08069
PHAROS:  P08069
GTEx:  ENSG00000140443 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP08069
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 2 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
CCX

Query on CCX



Download:Ideal Coordinates CCD File
E [auth A]
F [auth A]
G [auth B]
H [auth B]
J [auth C]
E [auth A],
F [auth A],
G [auth B],
H [auth B],
J [auth C],
K [auth C],
M [auth D],
N [auth D]
3-cyano-N-{1-[4-(5-cyano-1H-indol-3-yl)butyl]piperidin-4-yl}-1H-indole-7-carboxamide
C28 H28 N6 O
GVZDPXYOJHKYRC-UHFFFAOYSA-N
GOL

Query on GOL



Download:Ideal Coordinates CCD File
I [auth B],
L [auth C]
GLYCEROL
C3 H8 O3
PEDCQBHIVMGVHV-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.79 Å
  • R-Value Free:  0.185 (Depositor), 0.195 (DCC) 
  • R-Value Work:  0.157 (Depositor), 0.169 (DCC) 
Space Group: H 3
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 189.346α = 90
b = 189.346β = 90
c = 115.92γ = 120
Software Package:
Software NamePurpose
REFMACrefinement
XDSdata reduction
XSCALEdata scaling

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2010-09-29
    Type: Initial release
  • Version 1.1: 2011-07-13
    Changes: Version format compliance
  • Version 1.2: 2019-12-25
    Changes: Advisory, Database references
  • Version 1.3: 2023-11-01
    Changes: Advisory, Data collection, Database references, Derived calculations, Refinement description